What should you check when evaluating GLP‑1 peptide suppliers? Focus on COA, reconstitution and real‑world supply status

GLP‑1 research peptides remain extremely popular right now, yet many members have run into supply‑related headaches: stock shortages, inconsistent purity, and poor handling guidance from vendors.

There are several critical points worth thinking through when picking a supplier for research‑use GLP‑1 peptides:

1. Batch‑specific matching COA

A generic copy‑pasted COA means very little. Always ask for a COA that exactly matches the batch number of your vial. HPLC purity results, impurity levels need to be clearly shown on the report.

2. Clear guidance for reconstitution & storage

Many problems come from improper reconstitution, not the peptide powder itself. Pay attention to solvent volume, slow wall‑side water addition, gentle swirling (never shaking), and refrigeration after mixing. Bad handling will degrade even high‑purity GLP‑1 material.

3. Current market supply reality

As most people here know, GLP‑1 class peptides face heavy regulatory pressure across North America. This creates frequent stock shortages, parcel seizure risks, and big price swings across different vendors.

4. RUO labeling requirement

All vials should be clearly marked “For Research Use Only, Not for human use”. This is the basic compliance requirement for research‑grade peptides.

If anyone has technical questions about COA reading, reconstitution or storage of GLP‑1 peptides, feel free to message me privately to discuss these technical details.

Disclaimer: All content is for research‑educational discussion only. This is not medical advice.